Sign in
4

Changes in Ownership

ATOSSA THERAPEUTICS, INC. Filed Acc 0000950170-25-073518

Options or other derivatives

  • Chief Financial Officer acquired 543,785 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rees Heather Chief Financial Officer 2025-05-15 Grant or award · Stock Option (right to buy) +543,785 543,785 D
Loading xslF345X05/ownership.xml…